FDA panel confronting peptide controversy
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G." ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
같은 사건, 다른 제목
FDA considers green-lighting unproven peptide injections boosted by RFK Jr as scientists issue warnings
FDA panel to consider loosening regulations for some peptides
Demand for unapproved peptides soars as influencers tout unproven health benefits
Health experts issue caution over unapproved peptides as FDA weighs easing restrictions
+2
FDA panel confronting peptide controversy
WATCH LIVE: FDA advisory panel considers use of peptides
The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
What's the deal with peptides? The hyped market under US review
+2